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Abstract
Here we present the development and implementation of a genome-wide reverse genetic screen in the budding yeast,
Saccharomyces cerevisiae, that couples high-throughput strain growth, robotic RNA isolation and cDNA synthesis, and
quantitative PCR to allow for a robust determination of the level of nearly any cellular RNA in the background of *5,500
different mutants. As an initial test of this approach, we sought to identify the full complement of factors that impact pre–
mRNA splicing. Increasing lines of evidence suggest a relationship between pre–mRNA splicing and other cellular pathways
including chromatin remodeling, transcription, and 39 end processing, yet in many cases the specific proteins responsible
for functionally connecting these pathways remain unclear. Moreover, it is unclear whether all pathways that are coupled to
splicing have been identified. As expected, our approach sensitively detects pre–mRNA accumulation in the vast majority of
strains containing mutations in known splicing factors. Remarkably, however, several additional candidates were found to
cause increases in pre–mRNA levels similar to that seen for canonical splicing mutants, none of which had previously been
implicated in the splicing pathway. Instead, several of these factors have been previously implicated to play roles in
chromatin remodeling, 39 end processing, and other novel categories. Further analysis of these factors using splicing-
sensitive microarrays confirms that deletion of Bdf1, a factor that links transcription initiation and chromatin remodeling,
leads to a global splicing defect, providing evidence for a novel connection between pre–mRNA splicing and this
component of the SWR1 complex. By contrast, mutations in 39 end processing factors such as Cft2 and Yth1 also result in
pre–mRNA splicing defects, although only for a subset of transcripts, suggesting that spliceosome assembly in S. cerevisiae
may more closely resemble mammalian models of exon-definition. More broadly, our work demonstrates the capacity of
this approach to identify novel regulators of various cellular RNAs.
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Introduction
The coding portions of most eukaryotic genes are interrupted by
non-coding introns which must be removed prior to the translation
of their messenger RNAs (mRNA). Removal of introns from pre–
mRNAs is catalyzed by the spliceosome, a large and dynamic
ribonucleoprotein complex comprised of five small nuclear RNAs
(snRNAs) and at least 100 proteins [1]. Much of our knowledge
about the components that comprise the spliceosome as well as
their mechanisms of action has been derived from experiments
using the powerful genetic tools available in the budding yeast,
Saccharomyces cerevisiae. Indeed, although the RNA2 – RNA11 genes
originally identified in Hartwell’s forward genetic screen preceded
the discovery of splicing [2], the mechanistic characterizations of
these genes, since renamed PRP2 – PRP11, underlie current
models of the splicing pathway. Importantly, because the core
components of the spliceosome are highly conserved between
budding yeast and humans, the mechanistic details derived from
work in yeast have been instrumental in understanding mecha-
nisms of pre–mRNA splicing in higher eukaryotes.
The modern view of pre–mRNA splicing acknowledges the
integrated role of the spliceosome with several other aspects of
RNA processing. Whereas the historical view of splicing
envisioned a cascade of temporal events initiated by transcription,
followed by polyadenylation, and finalized with splicing and
export of mRNAs from the nucleus, it is now clear that these
pathways are not independent from one another but rather are
functionally coupled. Strong evidence in both yeast and higher
eukaryotes demonstrates that recruitment of the spliceosome to
intron-containing transcripts occurs co-transcriptionally [3–6],
mediated at least in part by physical associations between the C-
terminal domain (CTD) of RNA polymerase II and the U1 snRNP
[7]. A growing body of evidence also indicates that the landscape
of chromatin modifications encountered by transcribing polymer-
ase molecules can dictate the activity of the spliceosome at various
splice sites. For example, recent work has identified an enrichment
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within exonic sequences, suggesting a possible mechanism for
facilitating the identification of intron-exon boundaries [8,9].
Similarly, the rate of transcription by RNA polymerase II, which
can be impacted by chromatin marks, has also been shown to be
critical for dictating alternative splicing decisions [10]. Further-
more, it is also clear that splicing is coupled to downstream steps in
RNA processing. For example, the yeast Ysh1 protein [11,12],
which is the homolog of CPSF73, the mammalian endonuclease
required for 39 end processing, was originally identified as Brr5 in
a cold-sensitive screen for mutants defective in pre–mRNA
splicing [13]. Consistent with this observation, recent evidence
suggests that transcriptional pausing near the 39 end of genes is a
critical component of pre–mRNA splicing efficiency [14]. Despite
the increasing evidence of the interconnectivity of these pathways,
in many cases the mechanistic details which underlie these
functional relationships remain unclear. Our understanding of
these mechanistic connections would benefit from a more
complete understanding of the complement of factors through
which splicing is connected to these cellular processes.
A variety of recent genome-wide approaches have provided
important insights into the connections that exist between the
spliceosome and other cellular processes. Two powerful approach-
es, Synthetic Genetic Array (SGA) Analysis [15] and Epistatic
MiniArray Profiling (E-MAP) [16], leverage genetic tools available
in yeast to systematically generate millions of double-mutant
strains and then carefully quantitate their cellular fitness to
determine an interaction score for every pair-wise mutation. On
the basis of strong positive or negative genetic interaction scores
these approaches have been successfully used to infer functional
relationships between many cellular pathways, including several
with pre–mRNA processing [17,18]. Simultaneously, improve-
ments in proteomic methodologies have enabled the direct analysis
of protein complexes in organisms as diverse as humans and yeast,
allowing for an assessment of all of the stably-bound proteins
involved in pre–mRNA splicing in many organisms [19,20]. While
the combination of these and other approaches has provided a
global picture of many of the cellular factors that influence the
splicing pathway, either directly or indirectly, an important
question remains about the functional significance of these factors
in the splicing of specific transcripts. Indeed, it has long been
known that certain transcripts require the activity of unique
accessory factors to facilitate their splicing [21]. Moreover, recent
work supports the idea that different transcripts can have a greater
or lesser dependence upon the activity of core spliceosomal
components for their efficient splicing [22,23].
Here we present the results of a novel approach that
complements the genetic and physical approaches of others by
allowing for a direct functional assessment of nearly every gene in
the S. cerevisiae genome in the pre–mRNA splicing process. For this
work, we developed automated methods that enabled the isolation
of total cellular RNA from about 5500 unique strains, each of
which contained a mutation in a single gene, and all of which were
examined during exponential growth in liquid medium. Using a
high-throughput quantitative PCR (QPCR) assay, the relative
cellular level of nearly any RNA can be readily determined in the
background of each of these strains. By assessing the levels of
several different pre–mRNA species, we were able to identify not
only those factors which are necessary for the splicing of many
transcripts, but also factors that are specifically required for the
splicing of a subset of intron-containing genes. Whereas our study
specifically examines the levels of several cellular pre–mRNAs, the
approach described herein can be easily adapted to study the level
of nearly any RNA molecule of interest under a wide variety of
cellular growth conditions.
Results
A high-throughput method for measuring cellular levels
of specific RNA species
To identify the comprehensive network of cellular factors that
lead to a change in splicing efficiency, we developed a high-
throughput reverse genetic screen that allowed us to readily assess
changes in pre–mRNA levels in the background of ,5500
Saccharomyces cerevisiae strains, each of which contained a mutation
in a single gene. The library of strains contained deletions of non-
essential genes [24] as well as conditional mutations in essential
genes [25], accounting for mutational access to over 93% of
known yeast genes. Using a liquid-handling robot, protocols were
developed (see Materials and Methods) that allowed for the
simultaneous collection of each of these strains under exponential
growth conditions in liquid medium in 384-well plates. Total
cellular RNA was isolated robotically from each of these strains
using a phenol extraction protocol [23] followed by a glass-fiber
purification step [26]. After converting this RNA into cDNA using
a random-priming strategy, QPCR was used to directly measure
the level of a given RNA species within each strain. Because of the
inherent variability between the samples in the cell collection,
RNA isolation, and cDNA synthesis steps, the levels of six different
RNA species were measured in each of the samples in order to
calculate a normalization constant. On the basis of this
normalization constant, the relative level of virtually any cellular
RNA species can be determined in each of the mutant strains.
As an initial test of our approach we sought to identify the full
complement of factors involved in pre–mRNA splicing by
determining the relative levels of unspliced U3 small nucleolar
RNA (snoRNA) present in each of the mutant strains. The U3
snoRNA is unique in the S. cerevisiae genome in that it is the only
known non-coding RNA that is interrupted by a spliceosomal
intron [27]. Nevertheless, the U3 transcript has been widely used
historically as a splicing reporter, owing to its relatively high basal
expression level and the strong accumulation of U3 precursor
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[13,28,29]. As shown in Figure 1, the U3 precursor levels are
unaffected in the vast majority of the strains examined, with levels
varying by less than 1.35-fold from one another for 95% of the
strains. Indeed, only ,200 of the ,5100 strains that passed our
quality filters (see Materials and Methods) showed a change in the
relative U3 precursor levels of more than ,30% from the median
value (,0.35 in log2-transformed space), consistent with our
expectation that mutations in most genes will have little or no
effect on cellular pre–mRNA splicing efficiency. The tight
distribution of relative U3 precursor levels seen within this dataset
demonstrates the high precision with which these measurements
can be made, and suggests a low false discovery rate for our
approach.
Known spliceosomal components dominate the top
subset of mutations
To characterize the data generated by this approach we sought
to define the biological significance of those strains that showed
increased levels of U3 precursor. As an initial analysis, we
examined the U3 precursor levels in those strains containing
mutations in known splicing genes. Using the GO PROCESS:
RNA Splicing as a guide [30], a total of 71 strains in our library were
classified as containing mutations in canonical splicing factors
(Figure S1), of which 68 passed our quality filters for the U3
precursor dataset (see Materials and Methods). A strong
overrepresentation of these splicing factors can be seen within
the set of strains showing an enrichment of U3 precursor
(Figure 1A). Of the 68 strains containing splicing mutations that
passed our quality filters: 53 are found within the top 200 strains
(p=9.28E-64, Fisher’s exact test); 38 are found in the top 50
strains (p=1.33E-66); and the top 14 strains all belong to this list
(p=1.27E-27). Taken together, these data argue strongly that the
candidates identified by this approach will be characterized by a
high true positive discovery rate.
By contrast, out of the 68 strains containing mutations in known
splicing factors for which we obtained high quality data, 15 failed
to show an enrichment of U3 precursor levels in this dataset,
suggesting either that mutations in these genes don’t cause an
increase in U3 precursor levels (true negative), or that our
approach incorrectly failed to detect the accumulation of unspliced
U3 (false negative). To better resolve these possibilities we chose to
more completely examine the global splicing fitness of some of
these strains using splicing-sensitive microarrays. For every intron-
containing gene in the genome, these custom-designed micro-
arrays contain at least three probes (Figure 2A) that allow us to
distinguish between spliced and unspliced isoforms [31]. We used
these microarrays to assess the global splicing defects of four
mutants: two canonical splicing mutants that showed strong U3
precursor accumulation (snt309D and lsm6D, Figure 2B), and two
that showed little or no accumulation (mud2D and cus2D,
Figure 2C). As expected, and consistent with previous work from
others [32], the snt309D and lsm6D strains demonstrate a broad
splicing defect, with most intron-containing genes displaying an
increase in precursor levels accompanied by a decrease in the
amount of spliced mRNA. By contrast, the global splicing profiles
of the mud2D and cus2D strains are markedly different. In the cus2D
background, few intron-containing genes display a splicing defect:
very little precursor accumulation is observed, and there is little if
any detectable loss in mature mRNA. The mud2D mutation does
cause a splicing defect for some intron-containing genes, whereas
little change in splicing efficiency is seen for many others. Notably,
as seen in Figure 2D, the microarrays of both the snt309D and
lsm6D strains show a strong accumulation of U3 precursor levels,
whereas the mud2D and cus2D strains show almost no accumula-
tion, consistent with our QPCR screen results. It is worth noting
that in our experience the behavior of the U3 transcript differs
from the other intron-containing genes in that every splicing
mutation we have examined that causes an increase in the U3
precursor levels also results in an increase in the total level of U3; the
reason for this apparent discrepancy is currently under investiga-
tion. Nevertheless, these microarray data demonstrate that our
failure to detect an increase in U3 precursor levels in the mud2D
and cus2D strains does not represent a failure of the approach, but
rather that these are true negative results.
Assessing transcript-specificity of the mutants
To better assess the total complement of genes that can impact
the splicing of any precursor transcript, we chose to expand our
analysis by measuring the precursor levels of several additional
intron-containing genes. We chose to examine four ‘canonical’
intron-containing genes (RPL31B, UBC13, TUB3 and TEF5) that
vary in terms of intron size, transcriptional frequency, biological
function, and the presence or absence of an intron-encoded
snoRNA. In spite of these differences, these transcripts are similar
to one another in so much as they each contain splice site and
branch point sequences that conform to consensus sequences. In
addition to these four genes, we chose to examine two intron-
containing genes (YRA1 and REC107/MER2) that are known to be
poorly spliced under standard growth conditions [21,33,34]; as
such, we expected the behavior of these two transcripts to be
distinct from the efficiently spliced transcripts. For all six of these
genes, the precursor levels were measured in all ,5500 strains. As
an initial analysis of this data set, we considered the behavior of the
71 strains containing mutations in spliceosomal components
(Figure 3). As expected, precursor accumulation can be detected
for each of the canonical intron-containing transcripts in the
background of nearly all of the splicing mutations. While all four
canonical precursors accumulate in the mud2D background,
consistent with our microarray data, no precursor accumulation
is detected for any of these transcripts in the cus2D strain
(Figure 3B). In addition, several of the splicing mutants that failed
to cause an increase in the U3 precursor levels do cause a splicing
Figure 1. A subset of gene disruptions causes an increase in the
unspliced levels of U3 snoRNA. A. The relative level of U3 snoRNA
precursor in 5122 strains, ordered from the highest to lowest. Red data
points highlight the strains containing mutations in a factor within the
GO PROCESS: RNA Splicing category (see Figure S1). To the right, a box
and outlier plot for the same dataset. B. False color representation of
both the A (left) and B (right) biological replicates. The values are
ordered from high to low, mirroring the data in (A).
doi:10.1371/journal.pgen.1002530.g001
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Rec107 and Yra1 pre–mRNAs within this subset of strains differs
significantly from that seen for the canonically spliced transcripts.
Splicing of the Rec107 pre–mRNA shows a strong accumulation
in the upf1D and upf2D strains (Figure 3C), consistent with its
known degradation via the nonsense-mediated decay pathway
[35]. Because the Rec107 pre–mRNA does not engage the
spliceosome during vegetative growth [21], no precursor accumu-
lation is expected in strains containing spliceosomal mutations.
Likewise, the Yra1 pre–mRNA shows a strong accumulation in
the edc3D strain [34], consistent with its previously characterized
cytoplasmic degradation pathway. The failure to detect Yra1 pre–
mRNA accumulation in strains containing spliceosomal mutations
presumably reflects the inherently high levels of unspliced Yra1
transcript present in a wild type cell. Taken together, these data
strongly support the capacity of this approach to successfully
identify mutations that impact pre–mRNA splicing with low false
positive and false negative rates of discovery.
Global splicing efficiency is impacted by many cellular
mutations
To expand our analysis beyond previously characterized
splicing factors, we sought to identify novel mutations that caused
an increase in precursor levels in most, if not all, of our canonical
intron-containing genes. By determining the rank order of
precursor accumulation in each strain for each of the five
canonical splicing substrates (U3, Rpl31b, Tef5, Tub3, and
Ubc13 precursors), a composite rank order of each strain was
calculated as the average of these independent measurements
(Figure 4). Remarkably, while the majority of the mutations
examined cause little or no change in precursor levels of these four
transcripts, the subset of mutations which do cause detectable
increases in precursor levels is larger for some of the coding
mRNAs than was seen for U3. Interestingly, although there is
variation in the number of strains that cause pre–mRNA
accumulation of the different transcripts, with Tub3,Te-
f5,Ubc13,Rpl31b, strong overlap can nevertheless be identified
across the four transcripts. For example, the majority of the strains
that cause an increase in the Tub3 pre–mRNA also display an
increase in the pre–mRNA levels of the other three transcripts. By
contrast, many strains cause a strong accumulation of the Ubc13
and Rpl31b pre–mRNAs without causing a significant change in
the Tub3 or Tef5 pre–mRNA levels.
Because the absolute levels of the Rpl31b, Tef5, Tub3 and
Ubc13 pre–mRNAs are significantly lower than the U3 precursor
levels in most strain backgrounds (Table S1), we considered the
possibility that these results reflected a technical artifact associated
with measuring the cellular levels of low abundance RNA species
in certain strain backgrounds. Importantly, however, the relative
levels of the Rec107 pre–mRNA, whose normal cellular level is
Figure 2. Not all mutations in splicing factors result in defective splicing for all intron-containing genes. A. Splicing-sensitive
microarrays contain probes that target precursor (P), mature (M), and total (T) mRNA levels. B. Global splicing profiles of the snt309D and lsm6D
strains, showing a strong splicing defect for both mutants. C. Global splicing profiles of the mud2D and cus2D strains, illustrating different splicing
defects for these mutants. Whereas many transcripts show a splicing defect in the mud2D strain, many continue to be efficiently spliced. Similarly,
most intron-containing genes show no splicing defect in the cus2D strain. D. The behavior of specific transcripts in the different mutant backgrounds.
E. Locations within the U3 precursor dataset of the mutant strains for which microarrays are shown in (B) and (C).
doi:10.1371/journal.pgen.1002530.g002
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PLoS Genetics | www.plosgenetics.org 4 March 2012 | Volume 8 | Issue 3 | e1002530Figure 3. Mutations in most known splicing factors lead to increased precursor levels of canonical splicing substrates. Relative levels
of the indicated RNAs are shown in the background of all strains containing mutations in known splicing factors. The biological replicates (A and B)
are shown for each RNA. Precursor levels for all transcripts are ordered based on the average expression values of U3 precursor, from high to low
values. Gene disruptions are indicated on the left (-ts indicates a temperature sensitive allele). Insets to right indicate the location of the data in the
U3 precursor dataset. A. Mutations that lead to an increase in the U3 snoRNA. B. Mutations that do not affect U3 precursor levels but may affect the
levels of other intron containing genes. C. The increase of Rec107 precursor levels seen in the ufp1D and upf2D backgrounds, and the increase of Yra1
precursor levels seen in the edc3D background are consistent with their well-characterized degradation pathways.
doi:10.1371/journal.pgen.1002530.g003
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majority of the strains examined (Figure 4). Likewise, an analysis of
the cellular levels of the Faa1 mRNA, an intronless gene whose
transcript abundance is of a similar magnitude as the Rpl31b,
Tef5, Tub3 and Ubc13 pre–mRNAs, also shows a nearly constant
level in all of the examined strains, further suggesting that there is
no inherent bias in detecting low level transcripts. Finally, the Yra1
pre–mRNA, which is inefficiently spliced and has a higher
endogenous level than most pre–mRNAs, also shows very little
change in the examined strains. Taken together, these results
strongly support the conclusion that the levels of the Rpl31b, Tef5,
Tub3 and Ubc13 pre–mRNAs are increased in these strains.
Increases in precursor levels correlate with a decrease in
splicing efficiency
Because our approach, as described so far, directly measures the
cellular levels of precursor RNA but does not directly determine
the efficiency of splicing per se, those mutations which cause an
increase in the precursor levels could be doing so simply by
increasing the transcriptional frequency of these genes rather than
by directly impacting their splicing. To distinguish this possibility
from a true splicing defect, we chose to directly calculate the
splicing efficiency of the Tef5 transcript by measuring the total
cellular level of Tef5 mRNA by QPCR in each strain and using
this value to calculate the ratio of unspliced:spliced RNA in the
cell, a classical measure of splicing efficiency. Consistent with a
splicing rather than transcriptional cause for precursor accumu-
lation, the measured levels of total Tef5 transcript showed little
variation across nearly the entire set of strains (Figure S2). Indeed,
nearly every strain that showed an increase in Tef5 pre–mRNA
levels also showed a decrease in the splicing efficiency of the Tef5
transcript (Figure 4), suggesting that those mutations affect the
splicing of this transcript rather than its transcription. These results
strongly suggest that the increased pre–mRNA levels observed in
these strains largely reflect changes in pre–mRNA splicing.
To assess the functional significance of the strains displaying
increased pre–mRNA levels, we sought to rule out the possibility
that mutations which cause a change in overall cellular fitness
might indirectly lead to a decrease in overall splicing efficiency. To
test this, we compared our precursor accumulation levels with
recently described strain fitness data calculated for each of the
*5000 non-essential genes [36]. This comparison yielded no
correlation between precursor accumulation and cellular fitness
(Figure S2), suggesting that cellular growth rate alone is insufficient
to explain the observed increase in pre–mRNA levels.
Assessing the statistical significance of the precursor
accumulation
While the precursor accumulation seen for each of the canonical
transcripts in the known splicing mutants lends strong empirical
support for the overall robustness of our approach, additional
analysis was needed to assess the statistical significance of the data
we generated. Towards this end, we employed a statistical
approach originally developed for analysis of microarray data
called Significance Analysis of Microarrays [37], or SAM (see also
Materials and Methods). We chose this software because,
conceptually, the data generated by our QPCR approach are
orthogonal to those from a microarray experiment: whereas a
microarray experiment examines the behavior of thousands of
mRNAs in a single strain, here we examine the behavior of a
single RNA in thousands of different strains. Because similar
concerns regarding multiple hypothesis testing apply to both types
of data [38], we used this software as a tool for assessing the quality
of our data. The results of our SAM analysis were consistent with
the qualitative results seen in Figure 4, in so much as the number
of strains causing a statistically significant increase in the levels of
each precursor species varied depending upon the precursor
mRNA in question. A total of 224 strains caused a statistically
significant increase in the Rpl31b pre–mRNA levels, 209 strains
caused a significant increase in Ubc13 pre–mRNA levels, 146
strains caused a significant increase in U3 precursor levels, 83
strains caused a significant increase in Tef5 pre–mRNA levels, and
78 strains caused a significant increase in Tub3 pre–mRNA levels.
The complete list of SAM-identified strains for each RNA species
is provided in Table S2. Importantly, many of the SAM-identified
strains are found to cause a significant enrichment of the precursor
levels of all five of these RNAs, including the majority of strains
with mutations in canonical splicing factors.
Interestingly, for some of the species examined, a small number
of strains were identified which showed decreased levels of precursor
RNA. In certain instances these reflected expected outcomes: a
Figure 4. Increases in precursor levels correlate with a decrease
in splicing efficiency. A. Relative levels of the indicated RNAs are
shown in the background of 5334 strains. The data are ordered from
high to low values based on a composite rank order, determined on the
basis of the expression levels of the five canonical splicing substrates. B.
The relative splicing efficiency of the Tef5 transcript in each of these
strains, calculated as the relative Tef5 precursor levels divided by the
relative Tef5 total RNA levels. C. The relative levels of the low
abundance Rec107 pre–mRNA and Faa1 transcripts are shown along
with the inefficiently spliced Yra1 pre–mRNA, none of which shows a
similar pattern to the splicing defects seen in (A).
doi:10.1371/journal.pgen.1002530.g004
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strain, for example. However, in other cases these may indicate
important biological phenomena. For example, both the xrn1D
and the tfg2D strains cause a significant decrease in the U3
precursor levels. We have previously shown that deletion of the
Xrn1 nuclease paradoxically leads to decreases in many precursor
RNAs [39], although the mechanism by which this occurs remains
unknown. Likewise, it is unclear whether the decreased precursor
resulting from deletion of the TFIIF component Tfg2 reflects an
overall decrease in transcription of this gene, or whether this in
fact reflects increased splicing efficiency perhaps resulting from a
decreased transcription elongation rate [10].
Top screen candidates predict specific links between
splicing and several pre–mRNA processing pathways
To better characterize the factors that impact pre–mRNA
splicing, we examined our lists of SAM-identified candidates for
factors that are not canonical components of the spliceosome. As
an initial approach, we asked whether any functional categories of
proteins were statistically overrepresented within this set of strains.
For this analysis, we ordered the strains according to the largest
precursor accumulation that they affected for any of the RNA
species. We then used the GO::Term Finder program [40] to identify
overrepresented classes of genes. As expected, when considering
the 50 strains that caused the largest precursor accumulations, a
strong enrichment for splicing factors was seen with 30 out of 50
strains containing mutations in genes belonging to the GO
PROCESS: RNA Splicing category (p=1.3E-40 with Bonferroni
correction). Interestingly, when the top 100 strains are considered,
significant enrichment can also be seen for strains with mutations
in factors belonging to the GO PROCESS: Chromatin Remodeling
category, with eight different mutants causing precursor accumu-
lation (arp5D, arp8D, bdf1D, npl6D, rsc2D, rsc9-ts, vps72D, and yaf9D;
p=1.5E-03). Expanding our analysis to the top 200 candidates
increases the enrichment of this category to include twelve factors
(adding arp6D, swc5D, swr1D, and taf14D; p=1.8E-04). Interest-
ingly, within the top 200 candidates, significant enrichment is also
seen for the GO PROCESS: RNA Catabolic Process category, with
13 different factors being present (ccr4D, dis3-ts, dbr1D, kem1D,
lsm2-ts, lsm6D, lsm7D, prp18D, rrp6D, rtt101D, ski3D, ssn2D, and
upf3D; p=8.5E-03). Whereas some of these factors, such as lsm2-ts,
lsm6D, lsm7D, and prp18D are known to directly function in pre–
mRNA splicing, the identification of many of these factors
presumably reflects their defects in degradation pathways for
unspliced pre–mRNAs.
One of the top factors we identified that bridges chromatin
remodeling with transcription initiation is the bromodomain factor
Bdf1. Bdf1 is a member of the SWR1 complex and, along with its
homolog Bdf2, has been shown to interact with the TFIID
component of RNA polymerase II [41]. Moreover, BDF1 and
BDF2 have been demonstrated to be genetically redundant with
one another. Whereas our SAM analysis indicated that the bdf1D
caused a statistically significant accumulation of most of the
canonical precursor species in our experiments, the bdf2D strain
showed little or no detectable increase in the levels of any of the
precursors tested (Figure 5A), and was not considered by SAM
analysis to be significant for increases in any of the precursor
RNAs. To better characterize the global splicing profile of these
two mutants, we again turned to our splicing-sensitive micro-
arrays. Remarkably, a dramatic splicing defect can be seen in the
bdf1D strain for most intron-containing genes, as evidenced by an
increase in the precursor transcript levels with a concomitant
decrease in the mature and total transcript levels (Figure 5A). By
comparison, the bdf2D mutation has almost no effect on cellular
splicing, strongly corroborating the specific identification of Bdf1
in our screen. To better assess the mechanism by which Bdf1
impacts pre–mRNA splicing, we monitored U1 snRNP recruit-
ment in the background of wild-type, bdf1D, and bdf2D strains
using chromatin immunoprecipitation coupled to QPCR (ChIP-
QPCR). As seen in Figure S3, these experiments show that the
deletion of Bdf1 but not of Bdf2 decreases the occupancy of
U1snRNP at several intron-containing genes, suggesting impair-
ment of co-transcriptional spliceosomal recruitment in the bdf1D
strain. A more comprehensive ChIP-Seq experiment will be
required to fully characterize the global landscape of genes
impacted by the deletion of Bdf1 and further characterize the roles
of Bdf1 and Bdf2 in transcription and splicing.
We also chose to further examine several factors that our screen
identified that are more classically connected with chromatin
remodeling. The lower panels of Figure 5B and 5C show the
locations within our U3 precursor dataset of all of the strains
containing mutations in components of the SWR1 complex, and
the RSC complex, respectively. Notably, mutations in many but
not all of the components of these complexes cause a splicing
defect of the U3 transcript. Moreover, each of the five precursor
species that we examined shows a slightly different susceptibility to
the different components of these complexes. We chose to examine
the global splicing defects of strains containing mutations in two of
these components: Vps72, a member of the SWR1 complex; and
Rsc9, a member of the RSC complex. Splicing-sensitive micro-
arrays of the vps72D and rsc9-ts strains, respectively, reveal a
splicing defect in each strain (Figure 5B and 5C). However, unlike
the bdf1D strain, the vps72D and rsc9-ts strains cause a splicing
defect in only distinct subsets of intron-containing genes.
Interestingly, the affected subsets of transcripts are neither
completely overlapping nor completely independent of one
another; rather the microarray data are consistent with our
QPCR data in suggesting that mutations in specific chromatin-
modifying components can result in aberrant splicing of specific
pre–mRNA transcripts.
While an ontology-based approach can successfully identify
entire pathways that display enrichment, we were also interested in
considering those factors which showed strong pre–mRNA
accumulation but whose functional categories were not statistically
over-represented at the top of our dataset. Remarkably, while the
GO PROCESS: RNA 39 end Processing wasn’t significantly
overrepresented as a category within our dataset (9 out of top
200, p=0.09), several strains with mutations in factors belonging
to this category resulted in a strong, statistically-significant
accumulation of multiple precursor species. Included among these
were: yth1-ts, a zinc-finger containing protein that is the homolog
of human CPSF-30; cft2-ts, the homolog of human CPSF-100; and
fip1-ts, a component of the polyadenylation factor PF I. To further
examine the global splicing defects of each of these mutants,
microarrays were performed comparing mutant and wild type
behavior after shifting them to both elevated and reduced
temperatures. Of the three mutants, the profile seen in the yth1-
ts mutation most closely resembles a canonical splicing defect, with
more than half of the genes showing an increase of precursor and
loss of mature RNA (Figure 6A). Interestingly, the splicing defect is
strongest at reduced temperatures even though this strain has only
a subtle low-temperature growth defect (not shown). By compar-
ison, neither the cft2-ts nor the fip1-ts strains showed a strong
splicing defect at low temperature (not shown), but each mutant
was characterized by an unusual phenotype at elevated temper-
atures. As seen in Figure 6B and 6C, two distinct types of behavior
are seen in the cft2-ts and fip1-ts mutants, respectively, that are
largely defined by whether or not the affected transcript encodes a
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transcripts a canonical splicing defect is apparent, consistent with
our QPCR results. Interestingly, the subset of affected non-RPG
transcripts is different between the two mutant strains. By
comparison, nearly all of the RPG transcripts show a dramatic
increase in both the mature and total mRNA levels, with little or
no detectable change in precursor levels. The strong increases
caused by these mutants suggest that the RPG transcripts may be
subject to regulatory control at their 39 ends. Interestingly, while it
has long been known that RPG introns are, in general, longer than
non-RPG introns [42], whereas the second exons of RPGs tend to
be shorter than non-RPGs [5], we nevertheless find no strong
correlation between either intron or second exon length and the
strength of the splicing defect seen for these 39 end mutants (data
not shown). The mechanisms by which these 39 end factors impact
pre–mRNA splicing are currently under investigation.
Top screen candidates do not cause changes in the
cellular mRNA levels of most spliceosomal components
In considering the mechanisms by which candidate factors may
be functioning, we sought to determine whether any of the
candidates we examined might be indirectly affecting pre–mRNA
splicing by changing the cellular levels of known spliceosomal
components. Although our splicing-sensitive microarrays were
Figure 5. Mutations in chromatin remodeling factors can impact splicing in a global or transcript-specific manner. Splicing sensitive
microarrays of candidate factors (A) bdf1D and bdf2D, (B) vps72D, and (C) rsc9-ts, as compared to the phenotypes of known splicing mutants snt309D
and lsm6D. For each panel, the asterisk indicates the strain by which the data have been organized using hierarchical clustering, with the other data
sets in those panels sharing an identical gene ordering. The orange bar highlights the location of specific subsets of transcripts showing splicing
defects. The bottom insets show the location of each of the candidates within the U3 precursor dataset. Also, the locations of each of the
components of the SWR complex are shown in blue, and each of the components of the RSC complex are shown in green.
doi:10.1371/journal.pgen.1002530.g005
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intron-containing genes in S. cerevisiae, they also contain probes
against all ,6000 protein-coding genes and ,200 RNA genes,
including the spliceosomal snRNAs. Figure S4 shows the relative
RNA levels for each of the canonical spliceosomal components,
including the snRNAs, in the background of each of the different
strains we examined, as determined from our microarray analyses.
While these results positively recapitulate the expected changes (for
example, the decreases in Snt309 and Lsm6 mRNA levels in the
snt309D and lsm6D strains, respectively), with only a few
exceptions, most spliceosomal components appear unchanged in
most of the mutants we examined. Importantly, the transcript
encoding the Mud1 protein showed dramatic mis-regulation in
both the yth1-ts and cft2-ts strains, increasing by more than 10-fold
in each background. To test whether Mud1 overexpression might
be causing the splicing defects observed in these strains, a strain
was constructed where the wild type Mud1 transcript was encoded
on a high-copy plasmid. As seen in Figure S5, in spite of the over
30-fold increase in Mud1 levels in this strain, there is no detectable
change in pre–mRNA splicing. Therefore, while the mis-
regulation of Mud1 levels in these 39 end mutants suggests that,
similar to its human homolog, Mud1 levels in yeast may be subject
to negative regulation via its 39 end processing [43], it nevertheless
appears that the splicing defect observed in these strains is not a
consequence of Mud1 overexpression.
Interestingly, several of the strains, including bdf1D, yth1-ts, cft2-
ts, and fip1-ts, showed an ,2-fold increase in the levels of both the
U1 and U2 snRNAs. Although spliceosomes function as an
equimolar complex of all five snRNAs, the total cellular levels of
the snRNAs vary: in yeast, the U2 snRNA is the most abundant
[44], while in mammals the U1 snRNA is most abundant [45].
While recent work demonstrates the cellular defects associated
with decreased levels of snRNA [46], it is less clear whether
increases in their levels will impart a defect on global splicing.
Nevertheless, because each of these strains shows a similar increase
in these snRNA levels but distinct splicing defects, it seems unlikely
that the changes in snRNA levels alone can explain the observed
splicing phenotypes. However, it is not inconceivable that small
changes in levels for one or more of these transcripts could lead to
the observed splicing defects. As such, additional work will be
necessary to determine the functional consequences of these
mutations.
Discussion
A high-throughput, reverse genetic approach to measure
the cellular levels of specific RNA species
Here we present the results of a global survey designed to
identify the full subset of cellular factors in the budding yeast,
Saccharomyces cerevisiae, that impact the efficiency of pre–mRNA
splicing. As a complement to other recently described genetic and
physical genome-wide approaches, in this work we have developed
an approach that allows for a direct readout of the accumulation of
specific RNA species in the background of thousands of different
mutant strains. An important strength of a genome-wide screen
such as this is its unbiased approach. By directly measuring the
splicing efficiency of endogenous transcripts, this method avoids
bias generated using reporter constructs. Moreover, the ability to
examine numerous different transcripts allowed us to distinguish
the natural variation in the spliceosomal factors that are required
for efficient splicing of different intron-containing transcripts.
Indeed, by systematically examining the precursor levels in the
background of each strain, mutations can be identified which
result in a change in splicing efficiency regardless of their
previously described functions. In the work described here,
mutations in scores of genes with no previously known role in
splicing were identified, some of which impacted the splicing of all
five canonical transcripts examined and some of which impacted
only a subset of them. While some of these factors have been
further characterized and discussed here, many have not (see
Table S2). To be sure, as is the case with all genetic screens, it is
impossible on the basis of these screen data alone to ascribe a
direct role for any of these candidate factors in the splicing
pathway. Rather, the identification of these different factors can be
seen as generating a rich dataset from which hypotheses can be
generated and tested for their mechanistic underpinnings.
The 59 end: Connecting splicing with chromatin
remodeling and transcription initiation
Beyond known splicing factors, the most highly over-represent-
ed set of factors identified in this work function in chromatin
remodeling. One particularly interesting mutation that was
identified was the bdf1D mutant. In budding yeast, Bdf1 has been
demonstrated to play a role precisely at the interface of
transcription initiation and chromatin remodeling. Based in part
on its physical interaction with the Taf7 subunit of TFIID, yeast
Bdf1 has been proposed to function as the missing C-terminal
portion of the higher eukaryotic TAFII250 [41], the largest subunit
of the TFIID complex. More recently, it has become clear that
Figure 6. Mutations in 39 end processing mutants result in
transcript-specific splicing defects. Splicing sensitive microarrays
for the cleavage and polyadenylation factor mutants yth1-ts (A), cft2-ts
(B), and fip1-ts (C). For each panel, the data have been independently
organized using hierarchical clustering. The orange bar highlights the
location of specific subsets of transcripts showing splicing defects.
doi:10.1371/journal.pgen.1002530.g006
Genome-Wide Connections with Pre-mRNA Splicing
PLoS Genetics | www.plosgenetics.org 9 March 2012 | Volume 8 | Issue 3 | e1002530Bdf1 interacts with Swr1 and functions in recruiting the entire
SWR1 chromatin remodeling complex to nucleosomes. A recent
genome-wide study demonstrates that Bdf1 is enriched on the +1
and +2 nucleosomes of actively transcribed genes [47], and that it
coincides with the localization of Vps72, another component of
the SWR1 complex, and another component which was identified
in our screen (Figure 5).
Remarkably, we demonstrate here that the splicing of nearly
every intron-containing gene is negatively affected in a bdf1D
strain, and that the quantitative defect seen in this mutant rivals
that seen for canonical splicing mutants. Given its role in global
gene expression, one possible explanation for our results in the
bdf1D strain is that the transcription of some key splicing factor is
repressed by this mutation, causing a decrease in splicing
efficiency. Indeed, early work on Bdf1 from the Se ´raphin lab
suggested a role in global transcription, including transcription of
the spliceosomal snRNA genes [48]. However, our microarray
analyses show essentially normal RNA levels of all known splicing
components in the bdf1D strain (see Figure S4). Moreover, our
microarray data assessing the snRNA levels themselves are entirely
consistent with Se ´raphin’s original observations and demonstrate
that none of the five wild type snRNAs are decreased in cellular
level during growth at 30uC in the bdf1D mutant; rather, there are
subtle increases in the U1 and U2 snRNA levels. Importantly, our
ChIP-QPCR experiments in the bdf1D strain demonstrate a
decreased occupancy of the U1 snRNP on all four intron-
containing genes we tested, suggesting the intriguing possibility
that Bdf1 plays a direct role in connecting pre–mRNA splicing
with chromatin remodeling and transcription initiation.
In considering such a role for Bdf1, it is important to note that
the yeast BDF1 gene has a close sequence homolog in the BDF2
gene. These two genes are genetically redundant, in so much as
both single gene deletions are viable but the double mutant bdf1D/
bdf2D is lethal. Moreover, it has been shown that these two genes
evolved from a single ancestral gene following a whole-genome
duplication event [49]. Yet surprisingly, unlike the bdf1D strain,
the bdf2D strain showed no signs of a splicing defect either in our
screen or when examined by splicing sensitive microarrays.
Moreover, unlike the bdf1D strain, there was no apparent decrease
in U1 snRNP ChIP-QPCR signal in the bdf2D strain. In
considering a mechanism whereby Bdf1 connects transcription
initiation and chromatin remodeling with pre–mRNA splicing, it is
worth noting that, unlike human genes, the majority of yeast genes
do not contain an intron. As such, co-transcriptional recruitment
of the spliceosome is unnecessary for most yeast genes. We are
intrigued by the possibility that, in the time since the duplication
event, Bdf2 has evolved to a point where it retains the capacity to
recruit RNA polymerase but has lost the ability to efficiently
connect splicing with transcription. Such a scenario would explain
the differences observed between the bdf1D and bdf2D microarrays
and U1 snRNP ChIP-QPCR data. It would also likely explain the
previously published results that Bdf1 shows higher sequence
conservation with the C-terminal domain of human TAFII250
than does Bdf2 [41]. Given such a model for the divergence of
Bdf1 and Bdf2 functions, the differences in protein sequence
between these two proteins may prove informative for deciphering
the mechanism of Bdf1 activity.
The 39 end: Connecting splicing with cleavage and
polyadenylation
In addition to the over-representation of factors marking the 59
end of genes, our screen identified a number of factors involved in
the 39 end processing of mRNAs. Splicing-sensitive microarrays
confirm a broad splicing defect in a mutant of Yth1, the homolog
of human CPSF30, and transcript-specific splicing defects in
mutants of Cft2 and Fip 1, the homolog of human CPSF100 and a
component of the polyadenylation factor complex PF I, respec-
tively. In higher eukaryotes, components of the 39 end processing
machinery have been shown to physically associate with
components of the U2 snRNP [50] and U2AF65 [51]; moreover,
in vitro studies demonstrate a functional link between the pre–
mRNA splicing and 39 end processing pathways [52]. The
interactions between these two pathways in mammalian systems
have led to the proposal that the 39 end machinery plays an
important role in terminal exon definition. Whereas the exon-
definition model for mammalian spliceosome assembly posits that
internal exons are defined by interactions between U1 and U2
snRNP components across an exon [53], definition of terminal
exons is achieved by interactions between the 39 end processing
machinery and the U2 snRNP (Figure 7A), imposing a functional
connection between the pathways. Yet because of the relatively
short length of S. cerevisiae introns, and the limited number of genes
that are interrupted by multiple introns, splicing in yeast has long
been considered to proceed through a model of intron-definition.
Nevertheless, the Keller lab recently demonstrated that some
conditional alleles of YSH1/BRR5 lead to a decrease in splicing
efficiency [54]. Our demonstration here of pre–mRNA splicing
defects in the background of additional mutants in 39 end
processing mutants suggests the intriguing possibility that some of
the basic interactions that facilitate exon-definition in higher
systems may also be present in budding yeast. Indeed, further
characterizing the mechanism by which these 39 end processing
factors are affecting splicing in yeast may provide important
insights into the mechanisms by which exon-definition is
accomplished in higher eukaryotes.
A global perspective
An important strength of an approach such as this is the
genome-wide perspective that it provides. Figure 7B shows a
model of an idealized transcript along with the functional location
of a subset of the factors that have been examined in our screen. It
is striking to note that many of the factors identified here function
both during transcription initiation (Bdf1 and others) and
termination (Yth1, Cft2, Fip1, and others), thereby defining the
beginning and ends of the first and last exons, respectively. In this
work, we have identified not only those factors whose disruption
leads to a functional defect in splicing efficiency, but in many cases
the specific transcripts whose splicing is affected.
More broadly, the work presented here demonstrates the
feasibility of quantitating cellular RNA levels in the background of
large mutant strain collections. While our current approach
examined splicing efficiency in the context of optimized growth
conditions, a similar approach could be applied to identify factors
necessary for efficient splicing under varying cellular or develop-
mental growth states. Likewise, although our work focused on the
levels of several pre–mRNA species, this methodology should be




All experiments were performed using haploid strains. To assess
the function of non-essential genes, the mat a version of the
haploid deletion library from Open Biosystems [55] was used
(referred to herein as non-essential strains). Likewise, to assess the
function of essential genes, a collection of strains provided by the
Hieter lab [25] was used (referred to herein as essential strains). In
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mutations in core spliceosomal components was used (from here
on considered a part of the essential strains set). A complete list of
the strains used in this work is included in Table S3. Unless
otherwise indicated, all strains were grown in rich medium
supplemented with 2% glucose (YPD) [56]. When appropriate,
strains were recovered from frozen glycerol stocks on solid
medium supplemented with 200 mg/ml G418 grown at either
30uC (non-essential strains) or 25uC (essential strains). A manual
pinning tool (V&P Scientific, cat.#: VP384FP6) was used to
transfer cells from solid medium into 384-well microtiter plates
(Greiner BioOne, cat.#: 781271) for growth in liquid media.
Liquid cultures were grown in an Infors HT Multitron plate
shaker at 900 rpm with 80% constant humidity. Breathable
adhesive tape (VWR, cat.#: 60941-086) was used to seal the plates
and reduce evaporation.
Because the growth rates of the strains being used vary
significantly [36], an approach was developed to enable the
systematic collection of a similar number of rapidly dividing cells
for each strain. An initial liquid culture was grown in 384-well
plates for two days, allowing nearly all strains to reach
saturation. Because all of the strains being used are derived
from a common parental strain, the cell density for each of these
strains is nearly identical at saturation, allowing us to effectively
‘normalize’ the cell numbers. Using a liquid handling robot
(Biomek NX), 2 ml of saturated culture were used to inoculate a
fresh 150 ml of YPD. This culture was allowed to grow for four
hours, an amount of time which is sufficient to allow all strains to
exit lag-phase and begin exponential growth, but not so long as
to result in a large variation in cell densities among the strains
(Figure S6). For the non-essential strains, all growth was
conducted at 30uC. For the essential strains, the initial growth
was done at 25uC (a permissive temperature for all strains), but
the saturated cells were back-diluted into plates containing
media pre-warmed to 30uC (a non-permissive temperature for
many, but not all, of the strains) and allowed to continue growing
at 30uC for four hours. For both the non-essential and the
essential strains, two independent biological replicates were
initiated from each saturated plate. After four hours of
outgrowth, cells were harvested by centrifugation at 40006g
for five minutes. The cell pellets were flash frozen in liquid N2
and stored at 280uC until further processing.
Figure 7. The location of mutants that disrupt splicing suggests a similarity to exon-definition in mammalian splicing. A. Spliceosome
assembly in mammalian systems is thought to occur via exon-definition, where interactions between U1 and U2 snRNP components across an
internal exon, or CPSF components and U2 snRNP across a terminal exon, are necessary for efficient processing of the upstream intron. B. Functional
location of a subset of the mutants examined in this work, presented on a model transcript. Factors shown in red caused a statistically significant
increase in the precursor levels of at least one transcript in our screen, whereas those in grey did not affect the splicing of any of the transcripts.
doi:10.1371/journal.pgen.1002530.g007
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Isolation of total cellular RNA was performed using custom
protocols written for a Biomek NX liquid handling system. To
each frozen cell pellet collected as described above, 50 ml of Acid
Phenol: Chloroform (5:1, pH,5.5) and 25 ml of AES buffer
(50 mM sodium acetate (pH 5.3), 10 mM EDTA, 1%SDS) were
added. The plates were sealed with plastic CapMats (Greiner
BioOne, cat.#: 384070) and vortexed for five minutes at top speed
on a plate vortex. The plates were incubated for 30 minutes in a
water bath at 65uC with intermittent vortexing. After incubation,
the plates were spun for one minute at 10006g. An additional
35 ml of AES buffer was added to each well, and after mixing the
organic and aqueous phases were separated by centrifugation for
five minutes at 30006g. Using a slow aspiration speed, 40 ml of the
upper phase containing the RNA were robotically transferred to a
new 384-well microtiter plate. The transferred aqueous phase was
mixed with 3 volumes of RNA Binding Buffer (2 M Guanidine-
HCl, 75% isopropanol) and passed through a 384-well glass fiber
column (Whatman, cat.#: 7700-1101) by centrifugation for two
minutes at 20006g. The column was washed twice with two
volumes of Wash Buffer (80% ethanol, 10 mM Tris-HCl
(pH 8.0)), followed by a final dry spin for two minutes at
20006g. To remove any contaminating genomic DNA, 5 mlo f
DNase Mix (16DNase Buffer, 0.25 units of DNase I (Promega))
was added to each well and incubated at room temperature for
15 minutes. After the incubation, 80 ml of RNA Binding Buffer
was added to each well of the 384-well glass fiber plate and spun as
before. After washing and drying as above, 15 ml of sterile water
was added to each well of the glass-fiber plate to elute the RNA
into a clean 384-well microtiter plate (Greiner BioOne, cat. #:
781280). In general, this procedure yielded about 1 mg of total
cellular RNA from each cell pellet. The quality of the RNA
produced by this protocol is equal to our conventionally purified
samples, and the effectiveness of the DNase treatment is
demonstrated in Figure S7.
Synthesis of cDNA and quantitative PCR
Total cellular RNA was converted into cDNA in 384-well
microtiter plates. Of the 15 ml of RNA purified as described above,
10 ml were used in a cDNA synthesis reaction that had a total
volume of 20 ml and which contained 50 mM Tris-HCl (pH 8.3),
75 mM KCl, 3 mM MgCl2, 10 mM DTT, 0.5 mM each dNTP,
5 mgd N 9 primer, and 60 ng M-MLV RT. Reactions were
incubated overnight at 42uC.
The cDNA reactions were diluted 30-fold with water, giving a
final concentration of ,1n g / ml based on the initial RNA
concentration, and used without any further purification as
templates in high-throughput quantitative PCR (QPCR) reac-
tions. The QPCR reactions were performed in a reaction
volume of 10 ml, containing 5 mlo ft e m p l a t e( ,5n g o f
template), 10 mM Tris-HCl (pH 8.5), 50 mM KCl, 1.5 mM
MgCl2, 0.2 mM each dNTP, 0.256SYBR Green, 5% DMSO,
0.7 ng Taq DNA polymerase, and 250 nM forward and reverse
primers. The sequences of the primers used for each targeted
RNA are shown in Table S4. Standard curves were generated
consisting of 4-fold serial dilutions of genomic DNA and
covering a range of 1.6610
5 molecules. Each primer pair was
well-behaved, showing an amplification efficiency of between
8 6 %a n d9 7 %( F i g u r eS 8 ) .T w ot echnical replicates were
measured for each biologically independent sample, generating
four independent measurements for each of the ,5500 mutant
strains.
Processing QPCR data
On the basis of standard curves generated using QPCR, relative
nanogram quantities were calculated for every RNA transcript
within each of the ,5500 strains tested. To assess reproducibility,
coefficients of variation (CV) were determined for each primer pair
and each strain. The vast majority of these were highly
reproducible, both overall and on a per plate basis. As an initial
quality filter, we chose to exclude any samples for which the CV
was greater than 0.25.
Because no simple mechanism exists to normalize for
variability in each of our experimental steps, we instead chose
to measure the levels of six different RNAs in each of the samples
and use these to determine a composite normalization value to
account for the overall yield in our procedure. The six RNAs
were: U1 snRNA, Scr1 (SRP) RNA, Tef5 mRNA, Tub1 mRNA,
Srb2 mRNA and Faa1 mRNA. These RNAs were chosen
because their biological functions are diverse and their cellular
levels vary over a broad range (,300-fold, Table S1). For both
independent biological replicates of every strain, a composite
normalization constant, Cnormxi, was calculated according the
following formula:
For each primer pair, ngxi represents the relative nanogram
quantity calculated for an individual sample. Similarly, ngMEDPlate
represents the median value determined for a given primer pair
on an individual QPCR plate run. Because of the subtle
variations that are apparent from one plate run to the next, we
found that this per plate normalization using ngMEDPlate gave us




every primer pair, a relative abundance of total RNA can be
calculated for every sample. As seen in Figure S9, a histogram of
Cnormxi values follows a normal distribution in log2 space with a
variance of 1.5 units. A second filter at the level of Cnormxi values
was introduced which allowed for the filtering of samples with
very low amounts of cDNA.
For strains that passed this filter, the normalized levels of a given




The relative amount of RNA in a given strain was then








For each primer pair, RNAngnormxMEDPlate
represents the median
value of the normalized RNA levels determined within a given
QPCR plate. For each biological replicate of every strain, both the
ngxi and the RNArelxi values are available through Gene
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To determine the subset of strains that cause a statistically
significant increase or decrease in precursor levels, we employed
the Significance Analysis of Microarrays, or SAM, program [37]. While
this software was originally designed for the analysis of microarray
data, a significance analysis of our QPCR data is subject to similar
concerns regarding multiple hypothesis testing. For each RNA,
SAM analysis was performed on the four RNArelxi values,
comprised of both technical and biological replicates that were
generated for each of the ,5500 strains. For each transcript, a one
class SAM analysis was performed where the D value was adjusted
to minimize the false discovery rate (FDR), yielding the following
values: for the U3 precursor using D=0.983, FDR=0.045; for the
Tub3 pre–mRNA using D=0.91, FDR=0; for the Rpl31b pre–
mRNA using D=1.061, FDR=0.003; for the Ubc13 pre–mRNA
using D=0.978, FDR=0.002; and for the Tef5 pre–mRNA using
D=0.99, FDR=0.
Splicing-sensitive microarrays
The candidate non-essential deletion strains were grown to
saturation in YPD at 30uC, then back diluted in 25 ml cultures in
flasks at a starting A600,0.2 and allowed to grow at 30uC until
they reached an optical density of between A600=0.5 and
A600=0.7. The candidate essential strains were initially grown at
25uC in YPD, then shifted to the indicated temperatures for
15 minutes after they reached an optical density of between
A600=0.5 and A600=0.7. In parallel with the collection of the
mutant strains, wild type isogenic controls were grown and
collected under the same conditions as the mutant strains
examined. Total cellular RNA samples were isolated, converted
into cDNA, and fluorescently labeled as previously described [31].
All microarrays were performed as two-color arrays comparing
mutant and wild type strains, each grown under identical
conditions. Both raw and processed microarray data are available
through GEO using accession number GSE34330.
Chromatin immunoprecipitation
The U1C-Tap bdf1D and U1C-Tap bdf2D strains were
generated by deleting the appropriate genes in the background
of the U1C-Tap strain from Open Biosystems [57] using standard
techniques. The strains were grown at 30uC in rich medium
supplemented with 2% glucose (YPD) until they reached an optical
density of A600,0.7. The chromatin was cross-linked with 1%
formaldehyde for 2 minutes at 30uC. Glycine was added at a final
concentration of 125 mM and the cultures were left shaking for
another 5 minutes. Cell pellets from 50 ml of culture were
collected by centrifugation at 16206g for 3 minutes, then washed
with 25 ml ice-cold 16PBS and the pellet stored at 280uC. The
pellets were resuspended in 1 ml Lysis buffer (50 mM Hepes
pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% TritonX-100, 0.1%
Na-deoxycholate supplemented with protease inhibitors) and lysed
in the presence of 500 ml 0.5 mm glass beads in a beat beater. The
lysate was collected by centrifugation at 10006g for 1 minute, and
then pre-cleared by spinning for 15 minutes at 14000 rpm in a
tabletop centrifuge at 4uC. The pellet was re-suspended in another
1 ml of Lysis buffer and the chromatin was sheared to an average
size of 300 bp (range 100–500 bp) by means of a Bioruptor
sonicator. The sample was clarified by 2 cycles of centrifugation at
14000 rpm for 15 minutes in a tabletop centrifuge at 4uC and the
resultant chromatin solution frozen and stored at 280 C. From
the chromatin samples a 1% Input sample was retained, and then
each sample was split equally between a Mock IP and an IP
sample. The IP samples were incubated with 5 ml 0.5 mg/ml anti-
Tap Antibody (Thermo Scientific, CAB1001). After 2 hours at
4uC on a rotator, 25 ml of protein A/G-agarose resin (#Sc-
2003Santa Cruz) was added to all samples and they were further
incubated for another 2 h at 4uC. The resin was washed twice with
1 ml Lysis buffer, twice with 1 ml Wash buffer (10 mM Tris-HCl,
25 mM LiCl, 0.5% NP-40, 0.5%Na-deoxycholate, 1 mM EDTA)
supplemented with 360 mM NaCl, twice with 1 ml Wash buffer,
and finally twice with 1 ml TE. The first wash was a brief one,
followed by a 15 minute incubation of the samples on a rotator at
4uC for the second wash. In between washes, the resin was
collected by short spins at 2000 rpm in a tabletop centrifuge. The
resin was resuspended in 100 ul Elution buffer (50 mM Tris-HCl
pH 8.0, 5 mM EDTA, 1% SDS) and the immunoprecipitated
material was eluted from the beads by incubating at 65uC for
30 minutes with occasional tapping. To reverse crosslinks, the IPs
and the 1% Input samples were incubated overnight in a 65uC
water bath. The next day, the samples were treated with 12.5 ml
20 mg/ml Proteinase K solution and incubated at 42u for 2 h.
The DNA was then purified by using a Cycle Pure Kit (Omega
Bio-Tek, D6492-01) following the manufacturer’s instructions and
eluted in a final volume of 120 ml.
Quantitative real-time PCR was performed on a Roche Light
Cycler 480 machine as described above, using the 1% Input
sample to generate a standard curve for each of the primer pairs
we used. For the primers used in the screen, the sequences are
available in Table S4. The primers for the different regions of
actin gene and the PMA1 gene are the same as previously
published [5]. For each sample the Mock IP value calculated as
percent input was subtracted from the IP value (in percent input).
Then, a fold enrichment value was calculated, by dividing these
values by the PMA1 value.
Mud1 overexpression
An overexpressing plasmid containing a full-length copy of the
Mud1 gene including ,500 bp up- and down-stream of the ORF
was transformed into BY4741 (Open Biosystems). This strain and
a control strain containing the empty vector were grown in 25 ml
minimal media until they reached an optical density of A600,0.5–
0.6. RNA isolation was performed as previously described [31],
and cDNA synthesis and Q-PCR were performed as described
above. The primer sequences are found in Table S4.
Supporting Information
Figure S1 Splicing factors included within strain library.
Within the ‘‘GO process: RNA splicing’’ box are listed all
splicing factors as annotated by Gene Ontology [30]. These
factors have been subdivided based on the presence or absence
of a strain within our library, and further by the presence or
absence of data from our final filtered dataset. The subset
highlighted in red represents the strains which passed all the
filters in the U3 snoRNA precursor screen. Strains for which
there is ‘‘NO DATA’’ that passed our quality filters are listed
separately. Factors for which ‘‘NO STRAIN’’ was present in our
library are also noted. We ‘‘MANUALLY REMOVED’’ several
strains that are included by Gene Ontology but that we felt are
either are not part of the spliceosome or have a yet
uncharacterized function. In addition, we have ‘‘MANUALLY
ADDED’’ three factors which are known to impact splicing. Two
more strains that partially ‘‘DISRUPT READING FRAMES’’
of specific splicing factors (indicated in the parentheses) were also
added to our dataset.
(EPS)
Figure S2 Global changes in Tef5 RNA levels. A. Total RNA
levels of the Tef5 transcript in 5198 strains which passed the
Genome-Wide Connections with Pre-mRNA Splicing
PLoS Genetics | www.plosgenetics.org 13 March 2012 | Volume 8 | Issue 3 | e1002530quality filters. The total RNA levels are presented in log2 space as
a composite behavior of both biological replicates, and are ordered
from the highest (left) to the lowest (right) values. On the right side
of the figure the data are presented as a heat map, with both
biological datasets (A and B) shown. The data in the heat map are
ordered from the highest to the lowest values, similar to the
representation on the left. B. A comparison of the levels of Tef5
pre–mRNA versus the splicing efficiency of this transcript
(calculated as a ratio of precursor Tef5 to total Tef5 levels across
the entire dataset) shows a strong correlation. C. A comparison of
the relative growth rate of the non-essential library strains [36]
versus the Tef5 pre–mRNA levels reveals no correlation between
cellular fitness and splicing efficiency.
(EPS)
Figure S3 U1 snRNP recruitment is diminished upon Bdf1
deletion. Chromatin immunoprecipitation (ChIP) was performed
using a Tap tagged version of Yhc1 (U1C) in wild type, bdf1D, and
bdf2D strains to assess the co-transcriptional occupancy of the U1
snRNP. A) Primers that had been previously used in a similar
assay (Tardiff et al. Mol Cell 2006) allowed us to monitor by
quantitative PCR the amount of U1 snRNP associated with
different genomic regions of the ACT1 gene. The plotted values
were calculated as the percent of input signal detected at given
region within the actin gene divided by the percent of input signal
observed for the intronless gene PMA1. The error bars represent
the standard deviations of technical replicates. B) The ChIP
samples described above were assayed with the same primers used
in our screening which targeted intronic regions of the U3
snoRNA, Rpl31B and Ubc13 pre–mRNAs. As above, the values
are presented as fold enrichment over the intronless gene PMA1
and the error bars are indicate standard deviation of technical
replicates. For all four intron-containing genes, decreased levels of
U1 snRNP are detected in the bdf1D strain relative to both the
wild type and bdf2D strains.
(EPS)
Figure S4 The RNA levels of most spliceosomal factors are
unchanged in most mutants. Total RNA levels for all splicing
factors in the background of different gene deletions or point
mutations for which microarrays were performed. The data are
organized on the basis of the highest to the lowest average change
in the snt309D and lsm6D strains.
(EPS)
Figure S5 Mud 1 overexpression does not cause increases in
precursor levels. A high copy plasmid (2-micron) containing the
Mud1 gene was transformed into an otherwise wild type strain in
order to affect its overexpression. The expression levels of Mud1
and several precursor RNAs were monitored by quantitative real-
time PCR and compared to a wild type strain containing an empty
vector. The data were normalized to the expression of the
intronless Faa1 transcript to account for loading differences in the
samples. While a .30-fold increase is apparent for the Mud1
transcript, no increase is detected in the precursor levels of any of
the RNAs surveyed, suggesting that their splicing is unaffected by
Mud1 overexpression. The error bars represent the standard
deviation of technical replicates.
(EPS)
Figure S6 Growth rates of mutant strains in liquid culture.
Growth curves for a subset of 96 mutant deletion strains over a
600 minute time interval. Whereas the majority of the strains (A)
grow at a rate which is similar to wild type, a small number of
strains (B) grow at a slightly reduced rate, while one strain (C)
grows very slowly. On the basis of these data, we chose to harvest
cells after 4 hours of outgrowth, which ensures that the majority of
the strains are harvested when A600,0.5.
(EPS)
Figure S7 Assessing Total RNA and cDNA quality. A. A
comparison of RNA quality between a ‘‘classic’’ phenol-extraction
protocol and our robotic procedure. The diagram above the
picture of the gel indicates the regions of a 384-well plate from
which RNA was selected and run. Each lane contains about
300 ng of total cellular RNA and duplicates from each region of
the plate are shown. B. Effectiveness of the DNase treatment as
measured by quantitative RT-PCR, demonstrating the shift in
fluorescence before and after DNase treatment. The green text
indicates the samples that were treated with DNase, whereas the
black text indicates the untreated samples. C. The measured levels
of Tef5 pre–mRNA in the indicated samples demonstrates that the
contaminating genomic DNA is strongly depleted by DNase
treatment.
(EPS)
Figure S8 Standard curves for quantitative PCR (QPCR) for all
primer pairs. Standard curves for all primer pairs used in this
study. The Cp values (crossing points) are plotted against the
logarithm of known starting sample amounts (in nanograms of
genomic DNA). The equations that describe the curves as well as
the R
2 values are specified for each of the primer pairs.
(EPS)
Figure S9 Distribution of Cnorm values. The distribution of the
normalization constants (Cnorm) in log2 space for all samples in the
biological replicate A dataset. The area highlighted in dark green
comprises Cnorm values which have passed the Cnorm filter. All
log2(Cnorm) values less than 23 (an 8-fold decrease from the
median) were eliminated from the dataset. Above the histogram, a
box and outlier plot underlines the same distribution of Cnorm
values.
(EPS)
Table S1 Relative abundances of RNA species as measured by
QPCR. RNA species for which expression levels were measured
and their corresponding levels. The values are normalized to the
Tub3 pre–mRNA level, which was the lowest abundance
transcript measured in our experiments.
(DOCX)
Table S2 List of SAM identified strains and their SAM score for
the various pre–mRNAs measured. Strains which were found to
be statistically significant for any of the five precursor RNAs we
measured, arranged in the decreasing order of their maximal D
score generated by SAM.
(DOCX)
Table S3 The complete list of the strains used in this study. The
systematic names of all genes which were either deleted or
contained a temperature sensitive mutation are noted, as well as
their mutations and a reference to their sources. The sources are
a=Giaver et al., 2002; b=Ben-Aroya et al., 2008; c=from the
Guthrie lab collection.
(DOCX)
Table S4 Forward and Reverse primer sequences used for
QPCR for each target RNA. The list of forward and reverse
primers used in this study.
(DOCX)
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